{"id":13434,"date":"2022-07-19T14:50:39","date_gmt":"2022-07-19T12:50:39","guid":{"rendered":"https:\/\/lombardialifesciences.it\/eu4health-presentati-i-bandi-di-gara-del-secondo-semestre-2022\/"},"modified":"2023-10-17T09:37:14","modified_gmt":"2023-10-17T07:37:14","slug":"eu4health-presentati-i-bandi-di-gara-del-secondo-semestre-2022","status":"publish","type":"post","link":"https:\/\/lombardialifesciences.it\/en\/eu4health-presentati-i-bandi-di-gara-del-secondo-semestre-2022\/","title":{"rendered":"EU4Health: tutti i bandi di gara del secondo semestre 2022"},"content":{"rendered":"

I programmi di lavoro annuali di EU4Health (2021 e 2022) comprendono una serie di azioni che saranno attuate tramite appalti.<\/p>\n

EU4Health \u00e8 il quarto programma dell’Unione europea dedicato alla salute in vigore per il periodo 2021-2027.\u00a0<\/p>\n

Di seguito una panoramica dei bandi aperti e in arrivo per il secondo semestre 2022:<\/p>\n

CANCRO (CR)<\/span><\/strong><\/p>\n

CR-p-22-12.01 – Multiple Framework Contracts in Cascade for Support Actions in the Field of Tobacco Control
\nCR-p-22-11.01 – Study on obstacles for cancer survivors to return to work – il budget provvisiorio \u00e8 di \u20ac 500 000
\nCR-p-22-11.02 – Study on the development of a code of conduct on fair access of cancer survivors to financial services – il budget provvisorio \u00e8 di \u20ac 2 000 000
\nCR-p-22-12.01 – Framework contract (FWC) on the technical group supporting the characterising-flavours procedure in the tobacco legislation<\/p>\n

Preparazione alle crisi (CP)<\/strong><\/span><\/p>\n

CP-P-22-01.08 – Study on market research and mapping of innovative diagnostic testing solutions (HERA) – il budget provvisorio \u00e8 di \u20ac 200 000
\nCP-p-22-01.03 – IT tool for early warning, modelling, simulation, forecast in order to support the intelligence gathering and analysis function of HERA – il budget provvisorio \u00e8 di \u20ac 24 500 000 \u00a0
\nCP-p-22-01.02 – Procurement of vaccines against infectious disease threats such as pandemic influenza – il budget provvisorio \u00e8 di \u20ac 31 000 000<\/p>\n

Sistemi sanitari (HS)<\/span><\/strong><\/p>\n

HS-p-22-14.02 – Guidelines on access to healthcare for people with disabilities – il budget provvisorio \u00e8 di \u20ac 700 000
\nHS-p-22-18.03 – Supporting the cooperation between the national authorities and professional sector associations in the blood, tissue and cells and organs sectors – il budget provvisorio \u00e8 di \u20ac 750 000<\/p>\n

Programma di lavoro annuale 2021<\/strong><\/span><\/p>\n

HS-p-17.1 – Organisation of training and Networking of Substances of Human Origin (SoHO) Competent Authorities\u2019 Staff for Oversight – il budget provvisorio \u00e8 di\u00a0\u00a0\u20ac 2 500 000
\nCP-p-05.1 – EU preparedness: analysis, planning, reporting and training programmes for health specialists – il budget provvisorio \u00e8 di\u00a0\u00a0\u20ac 5 500 000<\/p>\n

Maggiori informazioni al seguente link<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

I programmi di lavoro annuali di EU4Health (2021 e 2022) comprendono una serie di azioni che saranno…<\/p>\n","protected":false},"author":1,"featured_media":12878,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[44],"tags":[76,377,111],"class_list":["post-13434","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-bandi","tag-eu4health","tag-finanziamenti"],"acf":[],"_links":{"self":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/13434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/comments?post=13434"}],"version-history":[{"count":1,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/13434\/revisions"}],"predecessor-version":[{"id":17927,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/13434\/revisions\/17927"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/media\/12878"}],"wp:attachment":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/media?parent=13434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/categories?post=13434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/tags?post=13434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}